Expired Canadian patentCanada
Use of transcription factor yb-1 in adenoviral systems
CA 2433071 C · Owner: Holm, Per Sonne · Inventors: Holm, Per Sonne
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention is related to a nucleic acid comprising an adenoviral nucleic acid, which also comprises a nucleic acid sequence coding for YB-1.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 21, 2001 and granted February 15, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 21, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 21, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 21, 2001
GrantedFebruary 15, 2011
Term endedDecember 21, 2021
Patent numberCA 2433071 C
Classification (IPC)C12N15/86 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.